Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
13.13
-0.02 (-0.15%)
At close: Sep 10, 2025, 4:00 PM
13.07
-0.06 (-0.46%)
After-hours: Sep 10, 2025, 5:11 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $251.09 million as of September 10, 2025. Its market cap has decreased by -32.36% in one year.
Market Cap
251.09M
Enterprise Value
9.35M
1-Year Change
-32.36%
Ranking
Category
Stock Price
$13.13
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $251.09M, a decrease of -93.92%. That is a compound annual growth rate of -48.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 252.63M | 35.11% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |